Bausch Health Companies Inc BHC
$8.35
+0.72%
at last close
Market Cap$3.10 billion
P/E Ratio—
Div Yield—
Volume2.33M
52-Week Range
$4.33$9.04
Analyst Ratings
- Consensus
- Hold — 0 Buy · 4 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $8.75 (+4.8% upside)
Key Stats
- Today's Range
- $8.20 – $8.46
- 50-Day Range
- $5.54 – $9.04
- 52-Week Range
- $4.33 – $9.04
- Volume
- 2.33 million shs
- Average Volume
- 3.82 million shs
- Market Cap
- $3.10 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.80%
- Days to Cover
- 4.27
About Bausch Health Companies Inc
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Related Stocks
Compare head-to-head: BHC vs LLY·BHC vs JNJ·BHC vs ABBV·BHC vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.